主页 文献库文献详情
PMID: 27650541 已发表 · aheadofprint 英语

Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.

Oncotarget ·0000-00-00

Ghazavi Farzaneh, De Moerloose Barbara, Van Loocke Wouter, Wallaert Annelynn, Helsmoortel Hetty H, Ferster Alina, Bakkus Marleen, Plat Geneviève, Delabesse Eric, Uyttebroeck Anne, Van Nieuwerburgh Filip, Deforce Dieter, Van Roy Nadine, Speleman Frank, Benoit Yves, Lammens Tim, Van Vlierberghe Pieter

摘要

Overwhelming evidence indicates that long non-coding RNAs have essential roles in tumorigenesis. Nevertheless, their role in the molecular pathogenesis of pediatric B-cell precursor acute lymphoblastic leukemia has not been extensively explored. Here, we conducted a comprehensive analysis of the long non-coding RNA transcriptome in ETV6/RUNX1-positive BCP-ALL, one of the most frequent subtypes of pediatric leukemia. First, we used primary leukemia patient samples to identify an ETV6/RUNX1 specific expression signature consisting of 596 lncRNA transcripts. Next, integration of this lncRNA signature with RNA sequencing of BCP-ALL cell lines and lncRNA profiling of an in vitro model system of ETV6/RUNX1 knockdown, revealed that lnc-NKX2-3-1, lnc-TIMM21-5, lnc-ASTN1-1 and lnc-RTN4R-1 are truly regulated by the oncogenic fusion protein. Moreover, sustained inactivation of lnc-RTN4R-1 and lnc-NKX2-3-1 in ETV6/RUNX1 positive cells caused profound changes in gene expression. All together, our study defined a unique lncRNA expression signature associated with ETV6/RUNX1-positive BCP-ALL and identified lnc-RTN4R-1 and lnc-NKX2-3-1 as lncRNAs that might be functionally implicated in the biology of this prevalent subtype of human leukemia.

关键词
BCP-ALL ETV6/RUNX1 LncRNA
文献信息
期刊
Oncotarget
期刊简称
Oncotarget
发表日期
0000-00-00
收录日期
2016-09-21
更新日期
2016-09-21
语言
英语
国家/地区
United States
NLM ID
101532965
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]